Showing results (201-210 of 217) with videos related to

Sort By:
Pageof 22
Investigational New Drugs|August 8, 2017
Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testingKyoungmin Lee, Changhoon Yoo, Kyu-Pyo Kim, et al.
BMC Cancer|November 27, 2014
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trialSeung Tae Kim, Yong Sang Hong, Ho Yeong Lim, et al.
Oncotarget|August 29, 2015
A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancerJai-Hee Moon, Jae-Sik Shin, Seung-Woo Hong, et al.
The Lancet. Oncology|September 10, 2014
Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trialYong Sang Hong, Byung-Ho Nam, Kyu-Pyo Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2019
Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled TrialYong Sang Hong, Sun Young Kim, Ji Sung Lee, et al.
British Journal of Cancer|May 21, 2020
Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysisChanghoon Yoo, Sang Soo Lee, Ki Byung Song, et al.
Plos One|April 13, 2019
Stereotactic body radiation therapy for locally advanced pancreatic cancerJinhong Jung, Sang Min Yoon, Jin-Hong Park, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2022
LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activationEunsil Sung, Minkyung Ko, Ju-Young Won, et al.
Molecular Cancer Therapeutics|September 10, 2015
Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor ActivityJae-Cheol Jo, Eun Kyoung Choi, Jae-Sik Shin, et al.
Investigational New Drugs|January 29, 2014
Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximabJeeyun Lee, Yong Sang Hong, Jung Yong Hong, et al.
Pageof 22